Parabiotic, Inc.

IBD: “Attack The Cause, Not Merely The Symptoms”

  • Stage Product In Development
  • Industry Biotechnology
  • Location Raleigh, NC, USA
  • Currency USD
  • Founded January 2011
  • Employees 2

Company Summary

Parabiotic Research & Development is an early stage company focused on the development of innovative drug combination products for the treatment of Inflammatory Bowel Disease (IBD) and infectious diseases.

Team

  • Ira Trachtman
    CEO

    Ira Trachtman has been a successful business executive with 40 years experience in various fields including, manufacturing, retail, design, product development and medical research. Throughout his career he has been considered an innovator with the ability to problem solve and “think outside the box” thru creative solutions.

  • David Dworaczyk
    President & COO

    Dr. Dworaczyk has over 30-yrs of experience in the pharmaceutical, biotechnology, medical device and CRO industry where he has held senior level positions in R&D, Global Operations, Business Development (L&A/M&A), Clinical Development, Strategic Planning, R&D Portfolio Analysis, Project Management and Commercial Operations. He has done extensive work with numerous healthcare, Pharma, Biotech and CRO focused Venture and Private Equity investment

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free